Article info
Technical video
Dual-agent percutaneous sclerotherapy technique for macrocystic lymphatic malformations
- Correspondence to Dr M Travis Caton, Neurointerventional Radiology, University of California San Francisco, San Francisco, CA 94143, USA; travis.caton{at}gmail.com
Citation
Dual-agent percutaneous sclerotherapy technique for macrocystic lymphatic malformations
Publication history
- Received June 13, 2022
- Accepted August 6, 2022
- First published August 17, 2022.
Online issue publication
August 17, 2023
Article Versions
- Previous version (17 August 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.